MIR8069-2

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, MIR8069-2 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated MIR8069-2 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher MIR8069-2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR8069-2 expression acts as an unfavorable survival marker.

UVM, GBM, and PCPG are the cancer types where MIR8069-2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
UVMOSTertileII,III,IV0.2180.718.00672view →
GBMOSTertileAll0.0760.415<.00127view →
PCPGDFSTertileAll0.6190.944.00218view →
PRADOSTertileAll0.4300.900<.0016view →
Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

MIR8069-2–UVM (OS)

Kaplan–Meier survival curve for MIR8069-2 RNA-high vs -low samples in UVM.

Open the UVM breakdown →

Exploration